[go: up one dir, main page]

WO2003011828A3 - Nouveaux analgesiques - Google Patents

Nouveaux analgesiques Download PDF

Info

Publication number
WO2003011828A3
WO2003011828A3 PCT/US2002/023686 US0223686W WO03011828A3 WO 2003011828 A3 WO2003011828 A3 WO 2003011828A3 US 0223686 W US0223686 W US 0223686W WO 03011828 A3 WO03011828 A3 WO 03011828A3
Authority
WO
WIPO (PCT)
Prior art keywords
attached
salt
integer
nitrogen
heterocyclic ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/023686
Other languages
English (en)
Other versions
WO2003011828A2 (fr
Inventor
Richard A Glennon
Billy R Martin
Malgozata Dukat
Imad M Damaj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Commonwealth University
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Priority to AU2002327340A priority Critical patent/AU2002327340A1/en
Publication of WO2003011828A2 publication Critical patent/WO2003011828A2/fr
Publication of WO2003011828A3 publication Critical patent/WO2003011828A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention se rapporte à un sel représenté par la formule I dans laquelle R?1, R2 et R3¿ sont indépendamment choisis dans le groupe consistant en groupes alkyles C¿1-6? ou n'importe lequel des R?1, R2 et R3¿ peuvent, ensemble avec l'atome de nitrogène auquel ils sont attachés, former un noyau hétérocyclique. R4 est choisi dans le groupe des fractions qui sont capables de modifier la solubilité du composé dans des fluides physiologiques et dans des supports pharmaceutiques, n est un chiffre entier compris entre 0 et 5, A est choisi dans le groupe hydrogène ou peut, avec le carbone auquel il est attaché et avec n'importe lequel des R?1, R2 et R3¿ et l'atome de nitrogène auquel ils sont attachés, former un noyau hétérocyclique. X est un contre-ion chargé négatif et p représente le nombre de charges négatives, le nombre de molécules de l'ion amino tertiaire chargé positif égal au chiffre entier p dans n'importe quel sel. De préférence, ce sel est représente par la formule II.
PCT/US2002/023686 2001-07-31 2002-07-25 Nouveaux analgesiques Ceased WO2003011828A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002327340A AU2002327340A1 (en) 2001-07-31 2002-07-25 3-pyridylether rerivatives and their use as analgesics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30855701P 2001-07-31 2001-07-31
US60/308,557 2001-07-31

Publications (2)

Publication Number Publication Date
WO2003011828A2 WO2003011828A2 (fr) 2003-02-13
WO2003011828A3 true WO2003011828A3 (fr) 2003-10-16

Family

ID=23194447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023686 Ceased WO2003011828A2 (fr) 2001-07-31 2002-07-25 Nouveaux analgesiques

Country Status (2)

Country Link
AU (1) AU2002327340A1 (fr)
WO (1) WO2003011828A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040682A1 (fr) * 1995-06-07 1996-12-19 Abbott Laboratories Composes d'ether heterocyclique de 3-pyridyloxyalkyle utiles pour reguler la transmission synaptique chimique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040682A1 (fr) * 1995-06-07 1996-12-19 Abbott Laboratories Composes d'ether heterocyclique de 3-pyridyloxyalkyle utiles pour reguler la transmission synaptique chimique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ABREO M A ET AL: "NOVEL 3-PYRIDYL ETHERS WITH SUBNANOMOLAR AFFINITY FOR CENTRAL NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 39, 1996, pages 817 - 825, XP002931256, ISSN: 0022-2623 *
HOLLADAY ET AL: "Neuronal Nicotinic Acetylcholine Receptros as Targets for Drug Discovery", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 40, no. 26, 19 December 1997 (1997-12-19), pages 4169 - 4194, XP002124847, ISSN: 0022-2623 *

Also Published As

Publication number Publication date
AU2002327340A1 (en) 2003-02-17
WO2003011828A2 (fr) 2003-02-13

Similar Documents

Publication Publication Date Title
NO20021399L (no) Kazolinderivater og deres anvendelse som farmasöyter
DK0731085T3 (da) Stilbenderivater og farmaceutiske sammensætinger indeholdende disse
CO5031285A1 (es) Triarilimidazoles
HK1046688A1 (zh) 喹唑啉化合物和含有喹唑啉化合物的藥物組合物
AU3686595A (en) Lta4 hydrolase inhibitors
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
WO2001062705A8 (fr) Derive d'aminoalcool
WO2003043961A3 (fr) Modulateurs de l'activite de rho c
MY112411A (en) Indole derivatives.
EP1479684A4 (fr) Thienopyrimidines, procedes de fabrication et d'utilisation correspondants
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
EP1400513A4 (fr) Compose diamine cyclique asymetrique
CA2355987A1 (fr) Derives d'amide bicycliques et leur emploi comme myorelaxants
SE0101038D0 (sv) Novel compounds
YU75394A (sh) Anelirani dihidropiridini i njihova primena za pripremanje farmaceutskih preparata
AR044175A1 (es) Compuestos de cefemo
MXPA05009607A (es) Derivados de n-fenil-[(4-piridil)-azinil]-amina como agentes protectores de plantas.
WO2003011828A3 (fr) Nouveaux analgesiques
CA2112061A1 (fr) Composes alkyliques heterocycliques substitues
MY122017A (en) Bis(acridinecarboxamide) and bis (phenazinecarboxamide) as antitumor agents
TW200510300A (en) Amino alcohol compounds
WO2003014089A8 (fr) Derives d'aminotetrahydroisoquinoleines en tant qu'analgesiques
TH32480A (fr)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP